Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-09-21T23:11:07.631Z.
Calculation as of: 2026-09-21T23:11:07.631Z.
Quote observation: 2026-09-21T20:00:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c3ee83f44a2efdd70b4cb60cd726217b4474c91f0f3ed8ed7c47805bb1a8d1c9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$1.89B
EV/EBIT Ratio
9.31x
TTM Avg
17.93x
3Y Avg
17.93x
5Y Avg
19.89x
Market Cap
$47.08M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.02B
EV/EBIT Ratio
41.81x
TTM Avg
48.09x
3Y Avg
65.08x
5Y Avg
65.08x
Market Cap
$5.10B
EV/EBIT Ratio
27.20x
TTM Avg
27.76x
3Y Avg
35.15x
5Y Avg
45.25x
Market Cap
$5.77B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.14B | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $479.36M | 38.41x | 21.35x | 18.47x | 19.70x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.89B | 9.31x | 17.93x | 17.93x | 19.89x |
| Shoulder Innovations, Inc. (SI)vs › | $363.33M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $47.08M | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $3.02B | 41.81x | 48.09x | 65.08x | 65.08x |
| Doximity, Inc. (DOCS)vs › | $5.02B | 24.51x | 30.12x | 39.46x | 57.26x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 27.20x | 27.76x | 35.15x | 45.25x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.77B | N/A | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.53B | 19.53x | 18.55x | 22.30x | 22.20x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
